UPDATED Nov 28, 2023
Investing in companies that think about the future will generate eco-friendly products and sustainable returns. As consumers become more environmentally-aware, demand will increase for these companies' products.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
8095Astena Holdings | JPÂ¥479.00 | -5.7% | 14.9% | JPÂ¥18.9b | n/a | PE104x | n/a | 3.8% | ||
4512Wakamoto PharmaceuticalLtd | JPÂ¥199.00 | -1.5% | -15.7% | JPÂ¥6.9b | n/a | n/a | n/a | n/a | ||
4564OncoTherapy Science | JPÂ¥25.00 | 0% | -59.0% | JPÂ¥5.4b | n/a | PS5.6x | n/a | n/a | ||
4588Oncolys BioPharma | JPÂ¥604.00 | 0% | 16.2% | JPÂ¥11.4b | n/a | PS44.7x | n/a | n/a | ||
4599StemRIM | JPÂ¥699.00 | 3.4% | -24.0% | JPÂ¥42.6b | JPÂ¥1,200.00 | PE253.6x | E-36.6% | n/a | ||
77773-D Matrix | JPÂ¥169.00 | 3.7% | -44.0% | JPÂ¥12.7b | n/a | PS4.7x | n/a | n/a | ||
4882Perseus Proteomics | JPÂ¥704.00 | -15.9% | 102.9% | JPÂ¥8.3b | n/a | PS85.3x | n/a | n/a | ||
4883Modalis Therapeutics | JPÂ¥127.00 | -1.6% | -63.0% | JPÂ¥4.0b | n/a | PB2x | n/a | n/a | ||
4586MedRx | JPÂ¥149.00 | -8.0% | 43.3% | JPÂ¥5.7b | n/a | PS72.4x | n/a | n/a | ||
4886ASKA Pharmaceutical HoldingsLtd | JPÂ¥1,800.00 | 0.06% | 40.7% | JPÂ¥51.0b | JPÂ¥2,400.00 | PE8.5x | E-5.2% | 2.2% | ||
4889Renascience | JPÂ¥447.00 | -3.5% | 35.0% | JPÂ¥5.7b | n/a | PS28.4x | n/a | n/a | ||
4596Kubota Pharmaceutical Holdings | JPÂ¥77.00 | 0% | -44.2% | JPÂ¥4.3b | n/a | PS119.9x | n/a | n/a | ||
4521Kaken Pharmaceutical | JPÂ¥3,343.00 | 1.3% | -15.2% | JPÂ¥125.3b | JPÂ¥3,500.00 | PE35.3x | E-29.5% | 4.5% | ||
4888Stella Pharma | JPÂ¥300.00 | -5.7% | -41.2% | JPÂ¥9.4b | n/a | PS32.3x | n/a | n/a |